1312290-04-2

Upstream product

• 4892-02-8 Methyl thiosalicylate 
• 382141-78-8 (2R,3S,4S,5R,6S)-2-(acetoxymethyl)-6-((2-(methoxycarbonyl)phenyl)thio)tetrahydro-2H-pyran-3,4,5-triyl triacetate 
• 382141-84-6 2-(methoxycarbonyl)phenyl 1-thio-β-D-galactopyranoside 
• 25878-60-8 D-galactose pentaacetate 
• 1312289-70-5 2-(methoxycarbonyl)phenyl 3-O-prop-2-ynyl-1-thio-β-D-galactopyranoside 
• 1517-05-1 2-azidoethanol 
• 1312289-94-3 2-[benzo(d)thiazol-2-ylcarbamoyl]phenyl 2,4,6-tri-O-acetyl-3-O-prop-2-ynyl-1-thio-β-D-galactopyranoside 
• 1312289-93-2 C₂₂H₂₄O₁₀S 
• 1312289-92-1 C₁₆H₁₈O₇S 

Downstream Products

• 1312289-76-1 2-[benzo(d)thiazol-2-ylcarbamoyl]phenyl 3-O-([1-(2-hydroxyethyl)-1H-1,2,3-triazol-4-yl]methyl)-1-thio-β-D-galactopyranoside 

Relevant academic research and scientific papers

Inhibitory potential of chemical substitutions at bioinspired sites of β-d-galactopyranose on neoglycoprotein/cell surface binding of two classes of medically relevant lectins

Galactose is the key contact site for plant AB-toxins and the human adhesion/growth-regulatory galectins. Natural anomeric extensions and 3′-substitutions enhance its reactivity, thus prompting us to test the potential of respective chemical substitutions